Research ExplorerPublications3 Jahre nach SYNTAX - Stent oder Skalpell? Die Sicht des Kar...

3 Jahre nach SYNTAX - Stent oder Skalpell? Die Sicht des Kardiochirurgen

Standard

3 Jahre nach SYNTAX - Stent oder Skalpell? Die Sicht des Kardiochirurgen. / Conradi, Lenard; Reichenspurner, Hermann.

In: Clinical research in cardiology supplements, Vol. 6, No. SUPPL.1, 2011, p. 43-48.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Conradi, L & Reichenspurner, H 2011, '3 Jahre nach SYNTAX - Stent oder Skalpell? Die Sicht des Kardiochirurgen', Clinical research in cardiology supplements, vol. 6, no. SUPPL.1, pp. 43-48. https://doi.org/10.1007/s11789-011-0023-5

APA

Conradi, L., & Reichenspurner, H. (2011). 3 Jahre nach SYNTAX - Stent oder Skalpell? Die Sicht des Kardiochirurgen. Clinical research in cardiology supplements, 6(SUPPL.1), 43-48. https://doi.org/10.1007/s11789-011-0023-5

Vancouver

Conradi L, Reichenspurner H. 3 Jahre nach SYNTAX - Stent oder Skalpell? Die Sicht des Kardiochirurgen. Clinical research in cardiology supplements. 2011;6(SUPPL.1):43-48. https://doi.org/10.1007/s11789-011-0023-5

Bibtex

@article{f9d0a631d24c4e6b84e26235ef09ed80,
title = "3 Jahre nach SYNTAX - Stent oder Skalpell? Die Sicht des Kardiochirurgen",
abstract = "Coronary artery bypass grafting (CABG) is the standard of care for patients with three-vessel or left main coronary artery disease. However, clinical practice has proven to differ substantially with even the most complex coronary lesions being targeted by percutaneous coronary intervention (PCI) today. An abundancy of both large registries and randomized clinical trials has demonstrated superiority of surgery over PCI in advanced coronary artery disease. Recently, these results have been confirmed by the landmark SYNTAX trial where CABG was found to be superior to PCI for three-vessel and/or left main coronary artery disease regarding repeat revascularization, rate of myocardial infarction, and cardiac mortality at the latest follow-up of 3 years. On the other hand, PCI proved to be a viable alternative for less complex forms of left main disease. In conclusion, patients with three-vessel and/or left main coronary artery disease should be discussed in an interdisciplinary heart team consisting of cardiologists and cardiac surgeons within a heart center. Final decision making should be a formal process as recommended in the recently updated guidelines on myocardial revascularization by the European Society of Cardiology.",
keywords = "Coronary surgery, Heart Team, Left main disease, Multi-vessel coronary artery disease, PCI",
author = "Lenard Conradi and Hermann Reichenspurner",
year = "2011",
doi = "10.1007/s11789-011-0023-5",
language = "Deutsch",
volume = "6",
pages = "43--48",
journal = "Clinical research in cardiology supplements",
issn = "1861-0706",
publisher = "Springer",
number = "SUPPL.1",

}

RIS

TY - JOUR

T1 - 3 Jahre nach SYNTAX - Stent oder Skalpell? Die Sicht des Kardiochirurgen

AU - Conradi, Lenard

AU - Reichenspurner, Hermann

PY - 2011

Y1 - 2011

N2 - Coronary artery bypass grafting (CABG) is the standard of care for patients with three-vessel or left main coronary artery disease. However, clinical practice has proven to differ substantially with even the most complex coronary lesions being targeted by percutaneous coronary intervention (PCI) today. An abundancy of both large registries and randomized clinical trials has demonstrated superiority of surgery over PCI in advanced coronary artery disease. Recently, these results have been confirmed by the landmark SYNTAX trial where CABG was found to be superior to PCI for three-vessel and/or left main coronary artery disease regarding repeat revascularization, rate of myocardial infarction, and cardiac mortality at the latest follow-up of 3 years. On the other hand, PCI proved to be a viable alternative for less complex forms of left main disease. In conclusion, patients with three-vessel and/or left main coronary artery disease should be discussed in an interdisciplinary heart team consisting of cardiologists and cardiac surgeons within a heart center. Final decision making should be a formal process as recommended in the recently updated guidelines on myocardial revascularization by the European Society of Cardiology.

AB - Coronary artery bypass grafting (CABG) is the standard of care for patients with three-vessel or left main coronary artery disease. However, clinical practice has proven to differ substantially with even the most complex coronary lesions being targeted by percutaneous coronary intervention (PCI) today. An abundancy of both large registries and randomized clinical trials has demonstrated superiority of surgery over PCI in advanced coronary artery disease. Recently, these results have been confirmed by the landmark SYNTAX trial where CABG was found to be superior to PCI for three-vessel and/or left main coronary artery disease regarding repeat revascularization, rate of myocardial infarction, and cardiac mortality at the latest follow-up of 3 years. On the other hand, PCI proved to be a viable alternative for less complex forms of left main disease. In conclusion, patients with three-vessel and/or left main coronary artery disease should be discussed in an interdisciplinary heart team consisting of cardiologists and cardiac surgeons within a heart center. Final decision making should be a formal process as recommended in the recently updated guidelines on myocardial revascularization by the European Society of Cardiology.

KW - Coronary surgery

KW - Heart Team

KW - Left main disease

KW - Multi-vessel coronary artery disease

KW - PCI

UR - http://www.scopus.com/inward/record.url?scp=84872024477&partnerID=8YFLogxK

U2 - 10.1007/s11789-011-0023-5

DO - 10.1007/s11789-011-0023-5

M3 - SCORING: Zeitschriftenaufsatz

C2 - 22528177

AN - SCOPUS:84872024477

VL - 6

SP - 43

EP - 48

JO - Clinical research in cardiology supplements

JF - Clinical research in cardiology supplements

SN - 1861-0706

IS - SUPPL.1

ER -